Total Payments
$415,633
2024 Payments
$49,305
Companies
37
Transactions
748
Medicare Patients
2,388
Medicare Billing
$3.6M
Payment Breakdown by Category
Other$301,739 (72.6%)
Consulting$78,800 (19.0%)
Travel$22,836 (5.5%)
Food & Beverage$12,139 (2.9%)
Education$103.21 (0.0%)
Gifts$15.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $274,139 | 112 | 66.0% |
| Consulting Fee | $78,800 | 35 | 19.0% |
| Honoraria | $27,600 | 10 | 6.6% |
| Travel and Lodging | $22,836 | 97 | 5.5% |
| Food and Beverage | $12,139 | 490 | 2.9% |
| Education | $103.21 | 3 | 0.0% |
| Gift | $15.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $243,310 | 222 | $0 (2022) |
| ABBVIE INC. | $101,794 | 129 | $0 (2024) |
| PIRAMAL CRITICAL CARE | $48,835 | 87 | $0 (2024) |
| Acorda Therapeutics, Inc | $14,957 | 17 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,250 | 67 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $950.61 | 8 | $0 (2024) |
| Genentech USA, Inc. | $660.01 | 53 | $0 (2024) |
| US WorldMeds, LLC | $580.17 | 2 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $445.66 | 14 | $0 (2024) |
| Biogen, Inc. | $394.48 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,305 | 117 | ABBVIE INC. ($29,594) |
| 2023 | $59,794 | 108 | AbbVie Inc. ($42,683) |
| 2022 | $62,302 | 115 | ABBVIE INC. ($29,441) |
| 2021 | $83,629 | 94 | Allergan, Inc. ($79,347) |
| 2020 | $27,059 | 77 | Allergan, Inc. ($25,948) |
| 2019 | $24,849 | 83 | Allergan Inc. ($24,178) |
| 2018 | $49,390 | 79 | Allergan Inc. ($45,724) |
| 2017 | $59,306 | 75 | Allergan Inc. ($47,028) |
All Payment Transactions
748 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $60.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.89 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/15/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $825.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.17 | General |
| Category: NEUROLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: PAIN | ||||||
| 09/25/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: Neurology | ||||||
| 09/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.56 | General |
| Category: NEUROLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $54.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/26/2024 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neurology | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Neurology | ||||||
| 08/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: PAIN | ||||||
| 08/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Neurology | ||||||
| 07/31/2024 | PIRAMAL CRITICAL CARE | GABLOFEN (Drug), GABLOFEN, GABLOFEN | Food and Beverage | In-kind items and services | $71.68 | General |
| Category: Pharmacology | ||||||
| 06/26/2024 | PIRAMAL CRITICAL CARE | GABLOFEN (Drug), GABLOFEN, GABLOFEN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Pharmacology | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 647 | 45,108 | $4.1M | $1.4M |
| 2022 | 19 | 596 | 48,464 | $3.4M | $1.0M |
| 2021 | 17 | 529 | 20,699 | $1.6M | $429,629 |
| 2020 | 19 | 616 | 18,749 | $2.4M | $702,095 |
Total Patients
2,388
Total Services
133,020
Medicare Billing
$3.6M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2023 | 18 | 17,400 | $2.0M | $791,963 | 39.6% |
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2023 | 15 | 3,900 | $1.1M | $428,746 | 40.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 27 | 22,400 | $672,000 | $101,775 | 15.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 79 | 139 | $22,518 | $10,183 | 45.2% |
| J0475 | Injection, baclofen, 10 mg | Office | 2023 | 11 | 105 | $48,038 | $8,041 | 16.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 52 | 53 | $34,450 | $7,911 | 23.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 22 | 136 | $23,664 | $6,240 | 26.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 27 | 62 | $93,000 | $5,858 | 6.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 12 | 37 | $11,248 | $3,971 | 35.3% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2023 | 19 | 46 | $15,548 | $3,291 | 21.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 18 | 52 | $5,720 | $2,880 | 50.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 12 | 36 | $12,816 | $2,868 | 22.4% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2023 | 19 | 56 | $11,592 | $2,808 | 24.2% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 27 | 27 | $17,550 | $2,545 | 14.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 40 | 71 | $11,502 | $2,348 | 20.4% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 12 | 32 | $9,728 | $2,302 | 23.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 21 | 21 | $9,450 | $2,097 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 20 | 26 | $5,382 | $1,749 | 32.5% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2023 | 12 | 26 | $8,034 | $1,435 | 17.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 34 | 87 | $9,570 | $1,204 | 12.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,718 | $1,089 | 29.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 21 | 45 | $13,500 | $944.81 | 7.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 19 | 32 | $4,000 | $675.49 | 16.9% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 11 | 11 | $4,950 | $652.08 | 13.2% |
| 95991 | Maintenance of spinal canal or brain drug infusion pump by health care professional | Facility | 2023 | 13 | 24 | $5,352 | $606.92 | 11.3% |
About Dr. Christopher Cronsell, MD
Dr. Christopher Cronsell, MD is a Physical Medicine & Rehabilitation healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831212109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Cronsell, MD has received a total of $415,633 in payments from pharmaceutical and medical device companies, with $49,305 received in 2024. These payments were reported across 748 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($274,139).
As a Medicare-enrolled provider, Cronsell has provided services to 2,388 Medicare beneficiaries, totaling 133,020 services with total Medicare billing of $3.6M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Milwaukee, WI
- Active Since 04/09/2007
- Last Updated 05/30/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1831212109
Products in Payments
- BOTOX (Biological) $307,625
- GABLOFEN (Drug) $48,268
- BOTOX (Drug) $24,131
- AMPYRA (Drug) $14,923
- BOTOX NEURO REHAB (Drug) $4,420
- BOTOX CHRONIC MIGRAINE (Drug) $3,307
- BOTOX - NEUROLOGY (Drug) $2,056
- Zilretta (Drug) $950.61
- KESIMPTA (Drug) $889.08
- MYOBLOC (Biological) $580.17
- OCREVUS (Biological) $514.48
- ZEPOSIA (Drug) $384.85
- BOTOX THERAPEUTIC (Biological) $272.08
- VYEPTI (Biological) $266.13
- DYSPORT (Drug) $250.42
- UBRELVY (Drug) $223.01
- BRIUMVI (Drug) $216.82
- Dysport (Drug) $195.24
- NURTEC ODT (Drug) $192.22
- AJOVY (Drug) $187.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Milwaukee
Dr. Nicholas Ketchum, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $640,689
Physical Medicine & Rehabilitation $640,689
Dr. John Mcguire, Md, MD
Physical Medicine & Rehabilitation — Payments: $90,251
Physical Medicine & Rehabilitation $90,251
Dr. Erin Mcgonigle, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $89,504
Physical Medicine & Rehabilitation $89,504
Dr. Brian Robertson-Dick, Md, MD
Physical Medicine & Rehabilitation — Payments: $69,100
Physical Medicine & Rehabilitation $69,100
Bindiya Shah, Do, DO
Physical Medicine & Rehabilitation — Payments: $9,988
Physical Medicine & Rehabilitation $9,988
Carla Wright, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $8,127
Physical Medicine & Rehabilitation $8,127